Multi-omics, machine learning, and molecular simulation identify CD44 as a candidate target in endocrine-disrupting chemical-associated thyroid cancer progression.
Combining multiple biological data types identifies potential new drug targets, opening pathways for treating difficult cancers.
This PubMed record reports a newly indexed biomedical study. The available metadata supports conservative classification as a observational cohort study.
What the study was
- Study design
- Observational cohort study
- Population
- Humans
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Molecular diversity
Why it surfaced
Observational cohort study; relevance and evidence were scored conservatively from the PubMed abstract.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.